author-photo

Stacy Cooper

Johns Hopkins University

19

Papers

61

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Pediatric Hodgkin Lymphoma, Version 3.2021.

2021 Journal of The National Comprehensive Cancer Network
Show All
- Source
- Cite
- Save
Citations (0)
Research and Care Networks in Acute Leukemia As a Model for Global Healthcare Collaboration

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
HL-032: Nivolumab and Brentuximab Vedotin (BV)–Based, Response-Adapted Treatment in Children, Adolescents, and Young Adults (CAYA) With Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Primary Analysis of the Standard-Risk Cohort of the Phase 2 CheckMate 744 Study

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Pediatric oncology provider perspectives and practices: Supporting patients and families in schooling after cancer diagnosis

2020 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (3)
The Process of Developing an Assessment Checklist for Simulated Infant Respiratory Distress Using a Modified Delphi Method: A Mixed Methods Study.

2020 Cureus
Show All
- Source
- Cite
- Save
Citations (0)
Post-Chemotherapy Titer Status and Need for Revaccination After Treatment for Childhood Cancer:

2020 Clinical Pediatrics
Show All
- Source
- Cite
- Save
Citations (1)
Improving Detection of Cancer Predisposition Syndromes in Pediatric Oncology.

2020 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Intrathecal chemotherapy-associated cerebral vasospasm in children with hematologic malignancies.

2020 Pediatric Research
Show All
- Source
- Cite
- Save
Citations (1)
Nivolumab and brentuximab vedotin (BV)-based, response‐adapted treatment in children, adolescents, and young adults (CAYA) with standard-risk relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Primary analysis.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Universal premedication and therapeutic drug monitoring for asparaginase‐based therapy prevents infusion‐associated acute adverse events and drug substitutions

2019 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (19)